|
Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation |
Brown T, Pilkington G, Bagust A, Boland A, Oyee J, Tudur Smith C, Blundell M, Lai M, Martin Saborido C, Greenhalgh J, Dundar Y, Dickson R |
|
|
Record Status This is a systematic review that meets the criteria for inclusion on DARE. Bibliographic details Brown T, Pilkington G, Bagust A, Boland A, Oyee J, Tudur Smith C, Blundell M, Lai M, Martin Saborido C, Greenhalgh J, Dundar Y, Dickson R. Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation. Health Technology Assessment 2013; 17(31): 1-278 Indexing Status Subject indexing assigned by NLM MeSH Antineoplastic Combined Chemotherapy Protocols /economics /therapeutic use; Carcinoma, Non-Small-Cell Lung /drug therapy /pathology; Carcinoma, Squamous Cell /pathology; Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Lung Neoplasms /drug therapy /pathology; Neoplasm Metastasis; Quality-Adjusted Life Years; Receptor, Epidermal Growth Factor /genetics AccessionNumber 12013041658 Date bibliographic record published 02/09/2013 |
|
|
|